Skip to product information
1 of 1

Human Insulin-Like Growth Factor-Binding Protein 6 (IGFBP6) ELISA Kit

Human Insulin-Like Growth Factor-Binding Protein 6 (IGFBP6) ELISA Kit

This ELISA kit is designed to detect Human Insulin-Like Growth Factor-Binding Protein 6 (Human IGFBP6). The assay plate has been pre-coated with mouse anti-Human IGFBP-6 monoclonal antibody. When the sample containing IGFBP-6 is added to the plate, it binds to the antibodies coated on the wells. Then, a horseradish peroxidase conjugated mouse anti-Human IGFBP-6 Antibody is added to the wells and binds to IGFBP-6 in the sample. After washing the wells, substrate solutions are added, and the color intensity is directly proportional to the amount of Human IGFBP-6 present. The reaction is stopped by adding an acidic stop solution, and the absorbance is measured at 450 nm.

Catalog No: BPE260
Regular price $624.00 USD
Regular price $480.00 USD Sale price $624.00 USD
Sale Sold out
Packaging
2 weeks
Download PDF

Product Details

Species Reactivity Human
Sensitivity 3.05 pg/mL
Detection Range 7.8-500 pg/mL
Sample Type Serum, plasma, cell culture supernates
Incubation(s) 3.5 hour(s)
Research Areas Signal Transduction, Cancer
Background Insulin-like growth factor-binding protein 6 (IGFBP6) is a 24-kDa protein that binds insulin-like growth factor 1 (IGF-1) and IGF-2 with high affinity and inhibits IGF action in vitro. The Insulin-like growth factor-binding protein also known as IGFBP serves as a carrier protein for Insulin-like growth factor 1. IGFBPs are distinct but are sharing regions with strong homology. All members of the IGFBP family bind IGF-I and IGF-II with about equal affinity. Insulin-like growth factor (IGF) binding proteins (IGFBPs) have been shown to either inhibit or enhance the action of IGF or act in an IGF-independent manner in the prostate. IGF-binding protein-4 (IGFBP-4) inhibits IGF-I action in vitro and is the most abundant IGFBP in the rodent arterial wall. IGFBP6 is directly downregulated by the beta-catenin/TCF complex in desmoid tumors, and imply a role for the IGF axis in the proliferation of desmoid tumors. There is mounting evidence that the structure of the IGFBP proteins plays a key role in the regulation of IGF bioavailability, by modulating its molecular size, capillary membrane permeability, target tissue specificity, cell membrane adherence, and IGF affinity.
Shipping Condition Shipped on cold gel packs.
Storage Condition and Shelf Life This product can be stored at 2-8C.
Analyte Insulin-like growth factor-binding protein 6
Regulatory Status For Research Use Only
View full details

Inquire about this product